Skip to main content

Nabel Gary J.'s Form 4 filing

Opko Health, Inc. (OPK) · filed May 8, 2023

Accession no.
0001209191-23-027852
Filed
May 8, 2023
Trade date
May 5, 2023
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 14 non-derivative transactions. Open-market purchases total $841.0K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Nabel Gary J.CIK 0001867450Director, Officer (Chief Innovation Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 5, 2023Common StockPPurchaseAcquired+19,285$1.78+$34,327.394,756Direct
May 5, 2023Common StockPPurchaseAcquired+3,185$1.79+$5,701.1597,941Direct
May 5, 2023Common StockPPurchaseAcquired+27,777$1.80+$49,998.6125,718Direct
May 5, 2023Common StockPPurchaseAcquired+27,624$1.81+$49,999.44153,342Direct
May 5, 2023Common StockPPurchaseAcquired+79,334$1.82+$144,387.88232,676Direct
May 5, 2023Common StockPPurchaseAcquired+19,475$1.83+$35,639.25252,151Direct
May 5, 2023Common StockPPurchaseAcquired+10,928$1.83+$19,998.24263,079Direct
May 5, 2023Common StockPPurchaseAcquired+28,538$1.82+$51,939.1619,886,052Indirect
May 5, 2023Common StockPPurchaseAcquired+26,407$1.85+$48,852.9519,912,459Indirect
May 5, 2023Common StockPPurchaseAcquired+54,945$1.82+$99,999.919,912,459Indirect
May 5, 2023Common StockPPurchaseAcquired+34,338$1.84+$63,181.92114,338Indirect
May 5, 2023Common StockPPurchaseAcquired+54,346$1.84+$99,996.64168,684Indirect
May 5, 2023Common StockPPurchaseAcquired+20,009$1.85+$37,016.65188,693Indirect
May 5, 2023Common StockPPurchaseAcquired+54,054$1.85+$99,999.9242,747Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)